119 related articles for article (PubMed ID: 22186617)
1. Genomics and pharmacogenomics of pancreatic adenocarcinoma.
Lowery MA; O'Reilly EM
Pharmacogenomics J; 2012 Feb; 12(1):1-9. PubMed ID: 22186617
[TBL] [Abstract][Full Text] [Related]
2. Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.
Das S; Cardin D
Curr Treat Options Oncol; 2020 Jun; 21(8):62. PubMed ID: 32601814
[TBL] [Abstract][Full Text] [Related]
3. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
[TBL] [Abstract][Full Text] [Related]
4. New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy.
Lowery MA; O'Reilly EM
BioDrugs; 2011 Aug; 25(4):207-16. PubMed ID: 21815696
[TBL] [Abstract][Full Text] [Related]
5. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
[TBL] [Abstract][Full Text] [Related]
6. Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.
Javed MA; Beyer G; Le N; Vinci A; Wong H; Palmer D; Morgan RD; Lamarca A; Hubner RA; Valle JW; Alam S; Chowdhury S; Ma YT; Archibugi L; Capurso G; Maisonneuve P; Neesse A; Sund M; Schober M; Krug S
Pancreatology; 2019 Jan; 19(1):97-104. PubMed ID: 30529068
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
Tappenden P; Jones R; Paisley S; Carroll C
Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities of palliation in pancreatic cancer].
Di Costanzo F; Sdrobolini A; Gasperoni S
Tumori; 1999; 85(1 Suppl 1):S47-53. PubMed ID: 10235081
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
10. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in pancreatic adenocarcinoma.
Squadroni M; Fazio N
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):386-94. PubMed ID: 20496553
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
Pishvaian MJ; Brody JR
Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab: still an option in the treatment of pancreatic cancer?
Faloppi L; Andrikou K; Cascinu S
Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
[TBL] [Abstract][Full Text] [Related]
14. Novel agents for the treatment of adenocarcinoma of the pancreas.
Mackenzie RP; McCollum AD
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1473-85. PubMed ID: 19828009
[TBL] [Abstract][Full Text] [Related]
15. Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review.
Garcia G; Odaimi M
J Gastrointest Cancer; 2017 Jun; 48(2):121-128. PubMed ID: 28303435
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
Rubinson DA; Wolpin BM
Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapies for pancreatic adenocarcinoma.
Lowery M; O'Reilly EM
Minerva Chir; 2009 Oct; 64(5):501-19. PubMed ID: 19859040
[TBL] [Abstract][Full Text] [Related]
18. Perspectives in the treatment of pancreatic adenocarcinoma.
Cid-Arregui A; Juarez V
World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
[TBL] [Abstract][Full Text] [Related]
19. Advanced stage pancreatic cancer: novel therapeutic options.
Saif MW
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):487-98. PubMed ID: 24939470
[TBL] [Abstract][Full Text] [Related]
20. Current adjuvant and targeted therapies for pancreatic adenocarcinoma.
Sanchez SE; Trevino JG
Curr Med Chem; 2008; 15(17):1674-83. PubMed ID: 18673217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]